177 related articles for article (PubMed ID: 34269730)
1. Cavernous Hemangioma: A Potential Pitfall at Delayed 18F-FDG PET/CT Scan.
Scolozzi V; Giancipoli RG; Macciomei MC; Vigna L; Leccisotti L
Clin Nucl Med; 2021 Dec; 46(12):e584-e586. PubMed ID: 34269730
[TBL] [Abstract][Full Text] [Related]
2. Hepatic Cavernous Hemangioma Mimicking Malignancy on 18 F-FDG PET/CT Imaging.
Zhang Y; Wang P; Shi X; Jing H
Clin Nucl Med; 2023 Dec; 48(12):1122-1123. PubMed ID: 37882763
[TBL] [Abstract][Full Text] [Related]
3. Detection of distant interval metastases after neoadjuvant therapy for esophageal cancer with 18F-FDG PET(/CT): a systematic review and meta-analysis.
Kroese TE; Goense L; van Hillegersberg R; de Keizer B; Mook S; Ruurda JP; van Rossum PSN
Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29917073
[TBL] [Abstract][Full Text] [Related]
4. Jejunal Cavernous Hemangioma Mimicking Malignancy With Increased Activity on 18 F-FDG PET/CT.
Huang WS; He YL; Liang J; Su YL; Xu JH
Clin Nucl Med; 2023 May; 48(5):409-410. PubMed ID: 36927765
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Burkitt lymphoma and cavernous sinus syndrome with breast uptake on 18F-FDG-PET/CT: A case report.
Reyneke F; Mokgoro N; Vorster M; Sathekge M
Medicine (Baltimore); 2017 Nov; 96(46):e8687. PubMed ID: 29145302
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 18F-FDG PET/CT imaging with different dual time 18F-FDG PET/CT with forced diuresis in clinical diagnosis of prostate cancer.
Yu L; Huang S; Wu S; Yue J; Yin L; Lin Z
Medicine (Baltimore); 2023 Jan; 102(2):e32331. PubMed ID: 36637950
[TBL] [Abstract][Full Text] [Related]
8. Role of
Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C
Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Prognostic Value of
Albano D; Familiari D; Fornito MC; Scalisi S; Laudicella R; Galia M; Grassedonio E; Ruggeri A; Ganduscio G; Messina M; Spada M; Midiri M; Alongi P
Curr Radiopharm; 2020; 13(1):42-47. PubMed ID: 31595860
[TBL] [Abstract][Full Text] [Related]
10. Rare perivascular epithelial cell tumor of the colon 18F-FDG PET/CT imaging: A case report.
Chen Q; Wang P; Zhang X; Zhang J
Medicine (Baltimore); 2023 May; 102(20):e33802. PubMed ID: 37335716
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET/CT and primary hepatic MALT: a case series.
Albano D; Giubbini R; Bertagna F
Abdom Radiol (NY); 2016 Oct; 41(10):1956-9. PubMed ID: 27259334
[TBL] [Abstract][Full Text] [Related]
12. Significance of 18F-FDG PET/CT in Characterization of Equivocal Lesions in High-Risk Testicular Carcinoma in Restaging Setting.
Rasheed R; Al-Kandari F; Ghanem M; Marafi F; Usmani S
Asian Pac J Cancer Prev; 2020 Feb; 21(2):511-515. PubMed ID: 32102532
[TBL] [Abstract][Full Text] [Related]
13. "Superscan" on F18‑fluorodeoxyglucose Positron Emission Tomography - Computed Tomography [18‑F] FDG PET-CT.
Muzaffar M; Hassan A
J Pak Med Assoc; 2021 Jul; 71(7):1907-1908. PubMed ID: 34410274
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG Positron Emission Tomography/Computed Tomography (PET/CT) for Distinguishing Tuberous Sclerosis Complex Lesions from Colon Cancer Metastases.
Mazurek A; Dziuk M; Witkowska-Patena E; Gizewska A; Piszczek S
Am J Case Rep; 2021 Oct; 22():e933320. PubMed ID: 34618793
[TBL] [Abstract][Full Text] [Related]
15. Dual-Time-Point 18 F-FDG PET/CT for Differentiating a Chest Wall Hemangioma From a Malignant Metastasis.
Lu HH; Chiu NT
Clin Nucl Med; 2023 Apr; 48(4):332-334. PubMed ID: 36728134
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma.
Abe Y; Tamura K; Sakata I; Ishida J; Ozeki Y; Tamura A; Uematsu K; Sakai H; Goya T; Kanazawa M; Machida K
Oncol Rep; 2012 Feb; 27(2):333-8. PubMed ID: 22024889
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET/CT features of pulmonary sclerosing hemangioma.
Lee E; Park CM; Kang KW; Goo JM; Kim MA; Paeng JC; Lee HJ; Park HS; Chung DH
Acta Radiol; 2013 Feb; 54(1):24-9. PubMed ID: 22291338
[TBL] [Abstract][Full Text] [Related]
18. Complete metabolic response to therapy of hepatic epithelioid hemangioendothelioma evaluated with 18F-fluorodeoxyglucose positron emission tomography/contrast-enhanced computed tomography: A CARE case report.
Giancipoli RG; Monti S; Basturk O; Klimstra D; Keohan ML; Schillaci O; Corrias G; Sawan P; Mannelli L
Medicine (Baltimore); 2018 Oct; 97(42):e12795. PubMed ID: 30334971
[TBL] [Abstract][Full Text] [Related]
19. Incidental 18F-FDG PET/CT bilateral breast uptake due to carcinoma.
Albano D; Bertoli M; Morassi ML; Bosio G; Orlando E; Bertagna F
Nucl Med Rev Cent East Eur; 2016; 19(B):14-16. PubMed ID: 27900755
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.
Ueda S; Tsuda H; Asakawa H; Shigekawa T; Fukatsu K; Kondo N; Yamamoto M; Hama Y; Tamura K; Ishida J; Abe Y; Mochizuki H
Jpn J Clin Oncol; 2008 Apr; 38(4):250-8. PubMed ID: 18407934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
